What Are Peptides for Nerve Damage

(default writer prompt)

input: Write a data-first, evidence-graded article: What Are Peptides for Nerve Damage
Slug: what-are-peptides-nerve-damage
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_laye

{
  "slug": "what-are-peptides-nerve-damage",
  "title": "What Are Peptides for Nerve Damage",
  "body": "## What's breaking down\nNerve damage occurs when axons break down faster than they can regrow. Myelin sheaths degrade. Inflammation persists. Blood supply to nerves drops. Mitochondria in neurons malfunction and fission increases. These layers compound: an initial injury triggers swelling that squeezes axons, cuts off nutrients, and slows repair signals. Without intervention that targets regeneration pathways, the imbalance continues and symptoms like pain, numbness, or weakness remain.\n\n## How these fit together\nPeptides studied for nerve damage often act on separate but linked layers. Some support axonal regrowth and myelination. Others reduce local inflammation or protect mitochondria. A few modulate pain signaling directly. When multiple compounds are considered together, their actions map to different parts of the repair process rather than overlapping on the same step.\n\n## What the evidence actually shows\nRat studies of BPC-157 after sciatic nerve transection showed faster axonal regeneration, thicker myelin, more myelinated fibers, better electromyography readings, and improved walking scores compared with controls (preclinical, source s11). A 2021 rat study found BPC-157 improved outcomes after spinal cord compression across acute to chronic phases (preclinic